Seraph Biosciences

About:

Seraph Biosciences is a developer of real-time pathogen detection systems used to treat infections.

Website: http://seraspec.com

Top Investors: Tech Startup Stabilization Fund

Description:

Seraph Biosciences is a biomedical device company developing real-time pathogen detection systems used to treat infections. By leveraging the principles of Raman Spectroscopy, Seraspec represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral, and fungal pathogens. Its product serves as a real-time handheld pathogen detection and identification device that enable health care providers to optimize clinical decision making in a globally integrated society.

Total Funding Amount:

$9.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Detroit, Michigan, United States

Founded Date:

2014-01-01

Contact Email:

office(AT)seraspec.com

Founders:

Charles Shanley, Gregory Auner, Mark Trexler

Number of Employees:

1-10

Last Funding Date:

2020-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai